Cangrelor: The Paradox of Choice

Affiliations

Free article

Editorial

Somjot S Brar. J Am Coll Cardiol. 2017.

Free article

. 2017 Jan 17;69(2):186-188.

doi: 10.1016/j.jacc.2016.11.020.

¹ Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. Electronic address: sbrar@cvri.org.

No abstract available

Keywords: anticoagulant agents; coronary artery disease; percutaneous coronary intervention; platelet aggregation inhibitors.

Comment on

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Vaduganathan M, et al. J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055. J Am Coll Cardiol. 2017. PMID: 28081827 Clinical Trial.